Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations

Anakinra (Kineret), a recombinant form of human interleukin-1 (IL-1) receptor antagonist, is approved for the treatment of rheumatoid arthritis (RA) in combination with methotrexate. Kineret is self-administered by daily subcutaneous injections in patients with active RA. The mechanism of action of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaiser, Christina, Knight, Ann, Nordström, Dan, Pettersson, Tom, Fransson, Jonas, Florin-Robertsson, Ebba, Pilström, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264859/
https://www.ncbi.nlm.nih.gov/pubmed/21881988
http://dx.doi.org/10.1007/s00296-011-2096-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3264859/
https://www.ncbi.nlm.nih.gov/pubmed/21881988
http://dx.doi.org/10.1007/s00296-011-2096-3

Ejemplares similares